EP80317

Also Known As:

Haic-D-2-Me-Trp-D-Lys-Trp-D-Phe-Lys-NH2

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

1.	Atherosclerosis 01/01/2019 - "EP80317 is an hexapeptide that serves as a ligand for CD36 and features protective effects under conditions such as atherosclerosis and vascular inflammation. "
2.	Inflammation (Inflammations) 01/01/2019 - "Taken together, these data indicate a strong therapeutic potential of EP80317 as a supportive treatment to control inflammation induced by scorpion envenomation." 01/01/2019 - "EP80317 Restrains Inflammation and Mortality Caused by Scorpion Envenomation in Mice." 01/01/2019 - "EP80317 is an hexapeptide that serves as a ligand for CD36 and features protective effects under conditions such as atherosclerosis and vascular inflammation. "
3.	Scorpion Stings 01/01/2019 - "In this study, we evaluated the effects of EP80317 treatment during experimental scorpion envenomation. " 01/01/2019 - "Taken together, these data indicate a strong therapeutic potential of EP80317 as a supportive treatment to control inflammation induced by scorpion envenomation." 01/01/2019 - "EP80317 Restrains Inflammation and Mortality Caused by Scorpion Envenomation in Mice."
4.	Atherosclerotic Plaque (Atheroma) 09/01/2009 - "Reportedly, hexarelin and EP80317 are capable of binding the CD36 in mouse macrophages and reducing atherosclerotic plaque deposition in mice. "
5.	Pneumonia (Pneumonitis) 01/01/2019 - "Importantly, EP80317 restrained lung inflammation and mortality caused by TsV in vivo. "